Impax Laboratories

Impax Laboratories, Inc. is a technology-based specialty Pharmaceutical company applying its formulation expertize and drug delivery technology to the development of controlled-release and specialty generics in addition to the development of branded products.
Hayward, US
1,290 (est)
Impax Laboratories was founded in 1999 and is headquartered in Hayward, US

Impax Laboratories Locations

Hayward, US
Philadelphia, US
Chalfont, US
Zhunan Township, TW

Impax Laboratories Metrics

Impax Laboratories Summary

Market capitalization

$917 M

Closing share price

Impax Laboratories's current market capitalization is $917 M.

Impax Laboratories Financials

Impax Laboratories's revenue is $860 M in FY, 2015 which is 44.36% increase from the previous period.
FY, 2013FY, 2014FY, 2015


$512 M$596 M$860 M

Gross profit

$199 M$313 M$352 M

Operating income

$-6.39 M$88.8 M$69.6 M

Operating expense total

$206 M$224 M$283 M

Net Income

$101 M$57.4 M$39 M

Operating cash flow

$42.5 M$30.3 M$125 M

    Impax Laboratories Market Value History

    Impax Laboratories News

    Impax Laboratories Company Life

    You may also be interested in